Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection
- PMID: 7664023
- DOI: 10.1007/BF01630480
Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection
Similar articles
-
Therapeutic applications of catalytic antisense RNAs (ribozymes).Ciba Found Symp. 1997;209:195-204; discussion 204-6. doi: 10.1002/9780470515396.ch14. Ciba Found Symp. 1997. PMID: 9383577 Review.
-
Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9. Adv Exp Med Biol. 1992. PMID: 1514448 Review. No abstract available.
-
Gene therapy for HIV.Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93. Sex Transm Infect. 2001. PMID: 11287684 Free PMC article. Review. No abstract available.
-
Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.Antisense Res Dev. 1991 Fall;1(3):285-8. Antisense Res Dev. 1991. PMID: 1821650 Review.
-
HIV and Ribozymes.Adv Exp Med Biol. 2015;848:97-116. doi: 10.1007/978-1-4939-2432-5_5. Adv Exp Med Biol. 2015. PMID: 25757617 Review.
Cited by
-
Anti-HIV ribozymes.Mol Biotechnol. 1997 Jun;7(3):241-51. doi: 10.1007/BF02740815. Mol Biotechnol. 1997. PMID: 9219238 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical